Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5,10-methylenetetrahydrofolate + FADH2
5,10-methylenetetrahydrofolate + FAD
-
Substrates: -
Products: -
?
5,10-methylenetetrahydrofolate + reduced ferredoxin
5-methyltetrahydrofolate + ferredoxin
-
Substrates: -
Products: -
?
5-methyltetrahydrofolate + 2 benzyl viologen
5,10-methylenetetrahydrofolate + 2 reduced benzyl viologen + 2 H+
5-methyltetrahydrofolate + 2 oxidized ferredoxin
5,10-methylenetetrahydrofolate + 2 reduced ferredoxin + 2 H+
-
Substrates: -
Products: -
r
5-methyltetrahydrofolate + benzyl viologen
5,10-methylenetetrahydrofolate + reduced benzyl viologen
5-methyltetrahydrofolate + FAD
5,10-methylenetetrahydrofolate + FADH2
-
Substrates: 11% of the activity with methylene blue
Products: -
?
5-methyltetrahydrofolate + menadione
5,10-methylenetetrahydrofolate + reduced menadiol
-
Substrates: 25% of the activity with methylene blue
Products: -
?
5-methyltetrahydrofolate + rubredoxin
5,10-methylenetetrahydrofolate + reduced rubredoxin
-
Substrates: 11% of the activity with methylene blue
Products: -
?
additional information
?
-
5-methyltetrahydrofolate + 2 benzyl viologen
5,10-methylenetetrahydrofolate + 2 reduced benzyl viologen + 2 H+
-
Substrates: -
Products: -
r
5-methyltetrahydrofolate + 2 benzyl viologen
5,10-methylenetetrahydrofolate + 2 reduced benzyl viologen + 2 H+
-
Substrates: -
Products: -
r
5-methyltetrahydrofolate + benzyl viologen
5,10-methylenetetrahydrofolate + reduced benzyl viologen
-
Substrates: -
Products: -
?
5-methyltetrahydrofolate + benzyl viologen
5,10-methylenetetrahydrofolate + reduced benzyl viologen
-
Substrates: 11% of the activity with methylene blue
Products: -
?
additional information
?
-
-
Substrates: no activity with pyridine nucleotides
Products: -
?
additional information
?
-
-
Substrates: reduced ferredoxin cannot be the physiological electron donor in vivo, since growth by acetogenesis from H2 + CO2 has a negative ATP yield. Reduced methyl viologen is used as electron donor for following the MVred:methylene-THF oxidoreductase activity during the purification procedure. With ethanol as product and Fdred as electron donor for the MetVF-type MTHFR, the ATP yield becomes slightly positive (0.14 ATP/ethanol). But since only minor amounts of ethanol are produced, this does not result in an overall positive ATP yield
Products: -
-
additional information
?
-
-
Substrates: the enzyme catalyzes reduction of methylenetetrahydrofolate with reduced benzyl viologen but not with NAD(P)H in either the absence or presence of oxidized ferredoxin. The enzyme also catalyzes the reversible reduction of benzyl viologen with NADH (diaphorase activity) at 48 U/mg
Products: -
?
additional information
?
-
-
Substrates: the enzyme catalyzes reduction of methylenetetrahydrofolate with reduced benzyl viologen but not with NAD(P)H in either the absence or presence of oxidized ferredoxin. The enzyme also catalyzes the reversible reduction of benzyl viologen with NADH (diaphorase activity) at 48 U/mg
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Habitual
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics.
Acquired Immunodeficiency Syndrome
[Superior mesenteric venous thrombosis. Report of 2 cases and review of the literature]
Arteriosclerosis
Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging.
Asthma
Is Folate Status a Risk Factor for Asthma or Other Allergic Diseases?
Cardiovascular Diseases
Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder.
Colorectal Neoplasms
Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis.
Coronary Artery Disease
Association of the methylene-tetrahydrofolate reductase gene rs1801133 C677T variant with serum homocysteine levels, and the severity of coronary artery disease.
Coronary Artery Disease
Relationship of the 1793G-A and 677C-T polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene to coronary artery disease.
cystathionine beta-synthase deficiency
Disorders of homocysteine metabolism.
Diabetes Mellitus
Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications.
Diabetes Mellitus, Type 2
Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications.
Diabetes Mellitus, Type 2
Reduced serum homocysteine levels in type 2 diabetes.
Down Syndrome
[Mutations in the methylene-tetrahydrofolate reductase gene and Down syndrome]
Folic Acid Deficiency
Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR.
Homocystinuria
Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging.
Hyperhomocysteinemia
Congenital MTHFR deficiency causing early-onset cerebral stroke in a case homozygous for MTHFR thermolabile variant.
Hyperhomocysteinemia
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
Hyperhomocysteinemia
Hyperhomocysteinemia and MTHFR C677T and A1298C polymorphisms are associated with chronic allograft nephropathy in renal transplant recipients.
Hyperhomocysteinemia
Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion.
Hyperhomocysteinemia
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics.
Hyperhomocysteinemia
Role of Genetic Background in Cardiovascular Risk Markers Changes in Water Polo Players.
Hypertension
Genotype of the CYBA promoter -930A/G, polymorphism C677T of the MTHFR and APOE genotype in patients with hypertensive disorders of pregnancy: An observational study.
Insulin Resistance
New risk factors for coronary heart disease in Asia.
Ischemic Stroke
Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Association between methylene-tetrahydrofolate reductase gene polymorphisms and chronic myeloid leukemia.
Leukoencephalopathies
Folate-induced reversal of leukoencephalopathy and intellectual decline in methylene-tetrahydrofolate reductase deficiency: variable response in siblings.
Lung Neoplasms
Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.
Lung Neoplasms
Prognostic significance of folate metabolism polymorphisms for lung cancer.
Lung Neoplasms
Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms.
Lung Neoplasms
The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk.
methylenetetrahydrofolate reductase (ferredoxin) deficiency
Folate-induced reversal of leukoencephalopathy and intellectual decline in methylene-tetrahydrofolate reductase deficiency: variable response in siblings.
methylenetetrahydrofolate reductase (ferredoxin) deficiency
Genetic defects of folate and cobalamin metabolism.
Neoplasms
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.
Neoplasms
Effects of folic acid deficiency and MTHFR C677T polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes.
Neoplasms
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Neoplasms
Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder.
Neural Tube Defects
Disorders of homocysteine metabolism.
Nijmegen Breakage Syndrome
Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Obesity
Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?
Obesity, Abdominal
New risk factors for coronary heart disease in Asia.
Osteonecrosis
The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.
Osteoporosis
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics.
Pre-Eclampsia
Genotype of the CYBA promoter -930A/G, polymorphism C677T of the MTHFR and APOE genotype in patients with hypertensive disorders of pregnancy: An observational study.
Scleroderma, Systemic
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
Small Cell Lung Carcinoma
Prognostic significance of folate metabolism polymorphisms for lung cancer.
Stroke
Homocysteine and risk of stroke.
Stroke
Homocysteine, renal function, and risk of cardiovascular disease.
Stroke
Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T.
Stroke
The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
Thrombophilia
Embryo implantation after assisted reproductive procedures and maternal thrombophilia.
Thrombophilia
Factor v Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke.
Thrombophilia
The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
Thrombophilia
[Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].
Thrombosis
Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion.
Thrombosis
Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics.
Thrombosis
[Superior mesenteric venous thrombosis. Report of 2 cases and review of the literature]
Thrombotic Stroke
Neonatal stroke associated with de novo antiphospholipid antibody and homozygous 1298C/C methylenetetrahydrofolate reductase mutation.
Urinary Bladder Neoplasms
Genetic variation in Glutathione S-Transferase Omega-1, Arsenic Methyltransferase and Methylene-tetrahydrofolate Reductase, arsenic exposure and bladder cancer: a case-control study.
Urinary Bladder Neoplasms
Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Uterine Cervical Neoplasms
Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
Vascular Diseases
Disorders of homocysteine metabolism.
Vascular Diseases
Homocysteine and risk of stroke.
Vascular Diseases
Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
Vascular Diseases
Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden.
Vascular Diseases
Hyperhomocysteinemia and MTHFR C677T and A1298C polymorphisms are associated with chronic allograft nephropathy in renal transplant recipients.
Venous Thromboembolism
The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism.
Vitamin B 6 Deficiency
[Deregulation of homocysteine metabolism and consequences for the vascular system]
Xeroderma Pigmentosum
Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.